European consensus guidelines on the management of neonatal respiratory distress syndrome

Journal of Perinatal Medicine

Volumn 35, Issue 3, 2007, Pages 175-186

  Sweet, David ^a   Bevilacqua, Giulio ^b   Carnielli, Virgilio ^c   Greisen, Gorm ^d   Plavka, Richard ^e   Didrik Saugstad, Ola ^f   Simeoni, Umberto ^g   Speer, Christian P ^h   Valls I Soler, Adolf ⁱ   Halliday, Henry ^j  

^a ROYAL MATERNITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF PARMA   (Italy)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^d Rigshospitalet   (Denmark)

^e CHARLES UNIVERSITY   (Czech Republic)

^f UNIVERSITY OF OSLO   (Norway)

^g HÔPITAL DE LA CONCEPTION   (France)

^h UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

ⁱ UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^j QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

more..

Author keywords

Continuous positive airways pressure; Evidence based practice; Mechanical ventilation; Oxygen supplementation; Patent ductus arteriosus; Respiratory distress syndrome; Surfactant therapy; Thermoregulation

Indexed keywords

ADRENALIN; ALPHA TOCOPHEROL; ANTIBIOTIC AGENT; BERACTANT; BETAMETHASONE; BLES; BOVACTANT; CALFACTANT; CORTICOSTEROID; DIPALMITOYLPHOSPHATIDYLCHOLINE; DOBUTAMINE; DOPAMINE; ERYTHROMYCIN; HYDROCORTISONE; IBUPROFEN; INDOMETACIN; LUCINACTANT; PHOSPHOLIPID; PORACTANT; PUMACTANT; RETINOL; STEROID; SUPEROXIDE DISMUTASE; SURFACTANT; SURFACTANT TA; UNCLASSIFIED DRUG; UTERUS SPASMOLYTIC AGENT;

ANTIBIOTIC PROPHYLAXIS; ARTIFICIAL VENTILATION; ASSISTED CIRCULATION; BLOOD PRESSURE REGULATION; BODY TEMPERATURE; CHEMOPROPHYLAXIS; CHRONOTHERAPY; CLINICAL TRIAL; CONSENSUS; CORTICOSTEROID THERAPY; DOSAGE SCHEDULE COMPARISON; DOSE RESPONSE; DRUG CHOICE; DRUG DOSE COMPARISON; DRUG TREATMENT FAILURE; EUROPE; EVIDENCE BASED MEDICINE; GESTATION PERIOD; HUMAN; HYPOTENSION; INTRAVENOUS ADMINISTRATION; LUNG DYSPLASIA; LUNG INFLATION; MEDICAL EXPERT; NEONATAL RESPIRATORY DISTRESS SYNDROME; NUTRITIONAL SUPPORT; OXYGEN THERAPY; PATENT DUCTUS ARTERIOSUS; PATIENT SAFETY; PERINATAL PERIOD; PNEUMONIA; PNEUMOTHORAX; POSITIVE END EXPIRATORY PRESSURE; PRACTICE GUIDELINE; PREMATURE LABOR; PRENATAL CARE; PRENATAL PERIOD; PRIORITY JOURNAL; REVIEW; SEPSIS; THERMOREGULATION; TREATMENT OUTCOME;

ENTERAL NUTRITION; EUROPE; HUMANS; INFANT, NEWBORN; OXYGEN INHALATION THERAPY; PRENATAL CARE; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, NEWBORN; SURFACE-ACTIVE AGENTS;

EID: 34247877594     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/JPM.2007.048     Document Type: Review

References (114)

1. 2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 13: Neonatal Resuscitation Guidelines. Circulation. 2005;112:IV-188-95.
2. Adamkin DH, McClead RE Jr, Desai NS, McCulloch KM, Marchildon MB. Comparison of two neonatal intravenous amino acid formulations in preterm infants: a multicenter study. J Perinatol. 1991;11:375-82.
3. Aghai ZH, Saslow JG, Nakhla T, et al. Synchronized nasal intermittent positive pressure ventilation (SNIPPV) decreases work of breathing (WOB) in premature infants with respiratory distress syndrome (RDS) compared to nasal continuous positive airway pressure (NCPAP). Pediatr Pulmonol. 2006;41(9):875-81.
4. American Academy of Pediatrics/American College of Obstetrics and Gynecology. Guidelines for Perinatal Care. 5th ed. 2002. ISBN: 0-915473-89-5.
5. Anotayanonth S, Subhedar NV, Garner P, et al. Betamimetics for inhibiting preterm labor. Cochrane Database Syst Rev. 2004;(4):CD004352.
6. Askie LM, Henderson-Smart DJ, Irwig L, et al. Oxygensaturation targets and outcomes in extremely preterm infants. N Engl J Med. 2003;349(10):959-67.
7. Attar MA, Donn SM. Mechanisms of ventilator-induced lung injury in premature infants. Semin Neonatol. 2002;7(5):353-60.
8. Barrington KJ, Finer NN. Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database Syst Rev. 2006;(1):CD000509.
9. Baud O, Foix-L'Helias L, Kaminski M, et al. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med. 1999;341:1190-6.
10. Baud O, Zupan V, Lacaze-Masmonteil T, et al. The relationships between antenatal management, the cause of delivery and neonatal outcome in a large cohort of very preterm singleton infants. Br J Obstet Gynaecol. 2000;107:877-84.
11. Bell EF, Acarregui MJ. Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2001;(3): CD000503.
12. Berseth CL, Nordyke CK, Valdes MG, Furlow BL, Go VL. Responses of gastrointestinal peptides and motor activity to milk and water feedings in preterm and term infants. Pediatr Res. 1992;31:587-90.
13. Bhuta T, Henderson-Smart DJ. Rescue high frequency oscillatory ventilation versus conventional ventilation for pulmonary dysfunction in preterm infants. Cochrane Database Syst Rev. 2000;(2):CD000438.
14. Bjorklund LJ, Ingimarsson J, Curstedt T, et al. Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs. Pediatr Res. 1997;42(3):348-55.
15. Bloom BT, Kattwinkel J, Hall RT, et al. Comparison of Infasurf (calf lung surfactant extract) to Survanta (Beractant) in the treatment and prevention of respiratory distress syndrome. Pediatrics. 1997;100(1):31-8.
16. Bloom BT, Clark RH, Infasurf Survanta Clinical Trial Group. Comparison of Infasurf (calfactant) and Survanta (beractant) in the prevention and treatment of respiratory distress syndrome. Pediatrics. 2005;116:392-9.
17. Bollen CW, Uiterwaal C, Van Vught AJ. Cumulative meta analysis of high frequency versus conventional ventilation in premature neonates. Am J Respir Crit Care Med. 2003;168:1150-55.
18. Boyer KM, Gotoff SP. Antimicrobial prophylaxis of neonatal group B streptococcal sepsis. Clin Perinatol. 1988;15:831-50.
19. Brion LP, Soll RF. Diuretics for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev. 2001;(2):CD001454.
20. Chow LC, Wright KW, Sola A, Oxygen Administration Study Group. Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants? Pediatrics. 2003;111(2):339-45.
21. Collaborative European Multicentre Study Group. Factors influencing the clinical response to surfactant replacement therapy in babies with severe respiratory distress syndrome. Eur J Pediatr. 1991;150:433-9.
22. Costeloe K, Hennessy E, Gibson AT, Marlow N, Wilkinson AR. The EPICure study: outcomes to discharge from hospital for infants born at the threshold of viability. Pediatrics. 2000;106:659-71.
23. Courtney S, Durand D, Asselin J, et al. Neonatal Ventilation Study Group. High-frequency oscillatory ventilation versus conventional mechanical ventilation for very-low-birth-weight infants. N Engl J Med. 2002;347(9):643-52.
24. Crowther CA, Harding J. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease. Cochrane Database Syst Rev. 2003;(3):CD003935.
25. Crowther CA, Haslam RR, Hiller JE, Doyle LW, Robinson JS, Australasian Collaborative Trial of Repeat Doses of Steroids (ACTORDS) Study Group. Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomized controlled trial. Lancet. 2006;367(9526):1913-9.
26. Cunningham S, Fleck BW, Elton RA, McIntosh N. Transcutaneous oxygen levels in retinopathy of prematurity. Lancet. 1995;346(8988):1464-5.
27. Darlow BA, Graham PJ. Vitamin A supplementation for preventing morbidity and mortality in very low birthweight infants. Cochrane Database Syst Rev. 2002;(4):CD000501.
28. Davis PG, Henderson-Smart DJ. Nasal continuous positive airways pressure immediately after extubation for preventing morbidity in preterm infants. Cochrane Database Syst Rev. 2003;(2):CD000143.
29. de Paoli AG, Davis PG, Faber B, Morley CJ. Devices and pressure sources for administration of nasal continuous positive airway pressure (NCPAP) in preterm neonates. Cochrane Database Syst Rev. 2002;(3):CD002977.
30. Ehlert CA, Truog WE, Thibeault DW, et al. II. Hyperoxia and tidal volume: independent and combined effects on neonatal pulmonary inflammation. Biol Neonate. 2006;90(2):89-97.
31. Erickson SJ, Grauaug A, Gurrin L, et al. Hypocarbia in the ventilated preterm infant and its effect on intraventricular haemorrhage and bronchopulmonary dysplasia. J Paediatr Child Health. 2002;38(6):560-2.
32. Fanaroff JM, Fanaroff AA. Blood pressure disorders in the neonate: hypotension and hypertension. Semin Fetal Neonatal Med. 2006;11(3):174-81.
33. Finer NN, Carlo WA, Duara S, et al. Delivery room continuous positive airway pressure/positive end-expiratory pressure in extremely low birth weight infants: a feasibility trial. Pediatrics. 2004;114(3):651-7.
34. Fiori HH, Fritscher CC, Fiori RM. Selective surfactant prophylaxis in preterm infants born at < or = 31 weeks' gestation using the stable microbubble test in gastric aspirates. J Perinat Med. 2006;34(1):66-70.
35. Flenady VJ, Woodgate PG. Radiant warmers versus incubators for regulating body temperature in newborn infants. Cochrane Database Syst Rev. 2003;(4): CD000435.
36. French NP, Hagan R, Evans SF, et al. Repeated antenatal corticosteroids: size at birth and subsequent development. Am J Obstet Gynecol. 1999;180(1 Pt 1):114-21.
37. Gerstmann DR, Minton SD, Stoddard RA, et al. The PROVO multicenter early high-frequency oscillatory ventilation trial: improved pulmonary and clinical outcome in respiratory distress syndrome. Pediatrics. 1996;98:1044-57.
38. Greenough A, Milner AD, Dimitriou G. Synchronized mechanical ventilation for respiratory support in newborn Cochrane Database Syst Rev. 2004;(4):CD000456.
39. Greisen G, Vannucci RC. Is periventricular leucomalacia a result of hypoxic-ischaemic injury? Hypocapnia and the preterm brain. Biol Neonate. 2001;79:194-200.
40. Gunn T, Reaman G, Outerbridge F, Colle E. Peripheral total parenteral nutrition for premature infants with respiratory distress syndrome: a controlled study. J Pediatr. 1978;92:608-13.
41. Halamek LP, Morley C. Continuous positive airway pressure during neonatal resuscitation. Clin Perinatol. 2006; 33(1):83-98.
42. Halliday HL. History of surfactant from 1980. Biol Neonate. 2005;87(4):317-22. Epub 2005 Jun 1.
43. Hartnoll G, Betremieux P, Modi N. Randomized controlled trial of postnatal sodium supplementation on body composition in 25-30 week gestational age infants. Arch Dis Child Fetal Neonatal Ed. 2000;82(1):F24-8.
44. Henderson-Smart DJ, Wilkinson A, Raynes-Greenow CH. Mechanical ventilation for newborn infants with respiratory failure due to pulmonary disease. Cochrane Database Syst Rev. 2002;(4):CD002770.
45. Henderson-Smart DJ, Bhuta T, Cools F, et al. Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants. Cochrane Database Syst Rev. 2003;(1): CD000104.
46. Ho JJ, Henderson-Smart DJ, Davis PG. Early versus delayed initiation of continuous distending pressure for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev. 2002;(2):CD002975.
47. Huang WL, Harper CG, Evans SF, et al. Repeated prenatal corticosteroid administration delays myelination of the corpus callosum in fetal sheep. Int J Dev Neurosci. 2001;19(4):415-25.
48. Ibrahim HM, Jeroudi MA, Baier RJ, Dhanieddy R, Krouskop RW. Aggressive early total parenteral nutrition in low-birth-weight infants. J Perinatol. 2004;24:482-6.
49. International Guidelines for Neonatal Resuscitation. An Excerpt From the Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care: International Consensus on Science. Pediatrics. 2000;106:e29.
50. Jobe AH, Ikegami M. Mechanisms initiating lung injury in the preterm. Early Hum Dev. 1998;53(1):81-94.
51. Jobe AH, Soll RF. Choice and dose of corticosteroid for antenatal treatments. Am J Obstet Gynecol. 2004;190(4):878-81.
52. Kamlin CO, O'Donnell CP, Davis PG, Morley CJ. Oxygen saturation in healthy infants immediately after birth. J Pediatr. 2006;148(5):585-9.
53. Kattwinkel J, Bloom BT, Delmore P, et al. High-versus low-threshold surfactant retreatment for neonatal respiratory distress syndrome. Pediatrics. 2000;106:282-8.
54. Kennedy KA, Tyson JE, Chamnanvanikij S. Early versus delayed initiation of progressive enteral feedings for parenterally fed low birth weight or preterm infants. Cochrane Database Syst Rev. 2000;(2):CD001970.
55. Kenyon S, Boulvain M, Neilson J. Antibiotics for preterm premature rupture of membranes. Cochrane Database Syst Rev. 2001;(4):CD001058.
56. Keszler M, Abubakar K. Volume guarantee of tidal volume and incidence of hypocarbia. Pediatr Pulmonol. 2004;38(3):240-5.
57. King J, Flenady V, Cole S, et al. Cyclo-oxygenase (COX) inhibitors for treating preterm labor. Cochrane Database Syst Rev. 2005;(2):CD001992.
58. King JF, Flenady VJ, Papatsonis DN, et al. Calcium channel blockers for inhibiting preterm labor. Cochrane Database Syst Rev. 2003;(1):CD002255.
59. Kinsella JP, Cutter GR, Walsh WF, et al. Early inhaled nitric oxide therapy in premature newborns with respiratory failure. N Engl J Med. 2006;355(4):354-64.
60. Kluckow M, Evans N. Relationship between blood pressure and cardiac output in preterm infants requiring mechanical ventilation. J Pediatr. 1996;129(4):506-12.
61. Knight DB. The treatment of patent ductus arteriosus in preterm infants. A review and overview of randomized trials. Semin Neonatol. 2001;6(1):63-73.
62. Lemyre B, Davis PG, De Paoli AG. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for apnea of prematurity. Cochrane Database Syst Rev. 2000;(3):CD002272.
63. Liptsen E, Aghai ZH, Pyon KH, et al. Work of breathing during nasal continuous positive airway pressure in pre term infants: a comparison of bubble versus variable-flow devices. J Perinatol. 2005;25(7):453-8.
64. Lloyd J, Askie L, Smith J, et al. Supplemental oxygen for the treatment of prethreshold retinopathy of prematurity. Cochrane Database Syst Rev. 2003;(2):CD003482.
65. Lorenz JM. Fluid and electrolyte therapy and chronic lung disease. Curr Opin Pediatr. 2004;16(2):152-6.
66. Lucas A, Bloom SR, Aynsley-Gren A. Gut hormones and "minimal enteral feeding". Acta Paediatr Scand. 1986;75: 719-23.
67. Lundstrom KE, Pryds O, Greisen G. Oxygen at birth and prolonged cerebral vasoconstriction in preterm infants. Arch Dis Child Fetal Neonatal Ed. 1995;73(2):F81-6.
68. Mayer-Mileur L, Chan G. Nutritional support of very-low-birth-weight infants requiring prolonged assisted ventilation. Am J Dis Child. 1986;140:929-32.
69. McCall EM, Alderdice FA, Halliday HL, et al. Interventions to prevent hypothermia at birth in preterm and/or low birthweight babies. Cochrane Database Syst Rev. 2005;(1):CD004210.
70. McCallion N, Davis PG, Morley CJ. Volume-targeted versus pressure-limited ventilation in the neonate. Cochrane Database Syst Rev. 2005;(3):CD003666.
71. McClure RJ, Newell SJ. Randomised controlled study of clinical outcome following trophic feeding. Arch Dis Child Fetal Neonatal Ed. 2000;82:F20-33.
72. Moya FR, Gadzinowski J, Bancalari E, et al. International surfaxin collaborative study group. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants. Pediatrics. 2005;115(4):1018-29.
73. Ng PC, Lee CH, Bnur FL, et al. A double-blind, randomized, controlled study of a "stress dose" of hydrocortisone for rescue treatment of refractory hypotension in preterm infants. Pediatrics. 2006;117(2):367-75.
74. Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev. 2005;(4): CD003481.
75. Osborn DA, Evans N. Early volume expansion for prevention of morbidity and mortality in very preterm infants. Cochrane Database Syst Rev. 2004;(2):CD002055.
76. Pandit PB, Dunn MS, Kelly EN, et al. Surfactant replacement in neonates with early chronic lung disease. Pediatrics. 1995;95(6):851-4.
77. Papatsonis D, Flenady V, Cole S, et al. Oxytocin receptor antagonists for inhibiting preterm labor. Cochrane Database Syst Rev. 2005;(3):CD004452.
78. Ramanathan R, Rasmussen MR, Gerstmann DR, et al. North American Study Group. A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants. Am J Perinatol. 2004;21(3):109-19.
79. Rivera A Jr, Bell EF, Bier MA. Effect of intravenous amino acids and protein metabolism of preterm infants during the first three days of life. Pediatric Res. 1993;33:106-11.
80. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2006;(3):CD004454.
81. Sandri F, Ancora G, Lanzoni A, et al. Prophylactic nasal continuous positive airways pressure in newborns of 28-31 weeks gestation: multicentre randomised controlled clinical trial. Arch Dis Child Fetal Neonatal Ed. 2004;89(5):F394-8.
82. Saugstad OD, Rootwelt T, Aalen O. Resuscitation of asphyxiated newborn infants with room air or oxygen: an international controlled trial: the Resair 2 study. Pediatrics. 1998;102(1):e1.
83. Saugstad OD. Oxygen for newborns: how much is too much? J Perinatol. 2005;25 Suppl 2:S45-9.
84. Saugstad OD, Ramji S, Vento M. Resuscitation of depressed newborn infants with air or pure oxygen: a meta-analysis. Biol Neouate. 2005;87:27-34.
85. Schmidt B, Davis P, Moddemann D, et al. Trial of indomethacin prophylaxis in preterms investigators. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med. 2001;344(26):1966-72.
86. Schmidt B, Roberts RS, Davis P, et al. Caffeine therapy for apnea of prematurity. N Engl J Med. 2006;354(20):2112-21.
87. Shaffer SG, Weismann DN. Fluid requirements in the preterm infant. Clin Perinatol. 1992;19(1):233-50.
88. Short BL, Van Meurs K, Evans JR, Cardiology Group. Summary proceedings from the cardiology group on cardiovascular instability in preterm infants. Pediatrics. 2006;117:S34-9.
89. Silverman WA, Ferting JW, Berger AP. The influence of the thermal environment upon the survival of newly born premature infants. Pediatrics. 1958;22:876-86.
90. Simmer K, Rao SC. Early introduction of lipids to parenterally-fed preterm infants. Cochrane Database Syst Rev. 2005;(2):CD005256.
91. Sinclair JC. Servo-control for maintaining abdominal skin temperature at 368C in low birth weight infants. Cochrane Database Syst Rev. 2002;(1):CD001074.
92. Sinha SK, Lacaze-Masmonteil T, Valls i Soler A, et al. Surfaxin therapy against respiratory distress syndrome collaborative group: a multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome. Pediatrics. 2005;115(4):1030-8.
93. Smaill F. Intrapartum antibiotics for group B streptococcal colonisation. Cochrane Database Syst Rev. 2000;(2):CD000115.
94. So KW, Fok TF, Ng PC, et al. Randomised controlled trial of colloid or crystalloid in hypotensive preterm infants. Arch Dis Child Fetal Neonatal Ed. 1997;76(1):F43-6.
95. Soll RF. Multiple versus single dose natural surfactant extract for severe neonatal respiratory distress syndrome. Cochrane Database Syst Rev. 2000;(2): CD000141.
96. Soll RF. Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2000;(2):CD000511.
97. Soll RF. Synthetic surfactant for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev. 2000;(2):CD001149.
98. Soll RF, Blanco F. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. Cochrane Database Syst Rev. 2001;(2):CD000144.
99. Soll RF, Morley CJ. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2001;(2):CD000510.
100. Speer CP, Robertson B, Curstedt T, et al. Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf. Pediatrics. 1992;89:13-20.
101. Speer CP, Gefeller O, Groneck P, et al. Randomized clinical trial of two treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome. Arch Dis Child Fetal Neonatal Ed. 1995;72(1):F8-13.
102. Stevens TP, Blennow M, Soll RF. Early surfactant administration with brief ventilation versus selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS. Cochrane Database Syst Rev. 2002;(2):CD003063.
103. Subhedar NV, Shaw NJ. Dopamine versus dobutamine for hypotensive preterm infants. Cochrane Database Syst Rev. 2003;(3):CD001242.
104. Subramaniam P, Henderson-Smart DJ, Davis PG. Prophylactic nasal continuous positive airways pressure for preventing morbidity and mortality in very preterm infants. Cochrane Database Syst Rev. 2005;(2):CD001243.
105. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. Pediatrics. 2000;105(2):295-310.
106. Tan A, Schulze A, O'Donnell CP, et al. Air versus oxygen for resuscitation of infants at birth. Cochrane Database Syst Rev. 2005;(2):CD002273.
107. Tyson JE, Kennedy KA: Trophic feeding for parenterally fed infants Cochrane Database Syst Rev. 2005;(3):CD000504.
108. Valls-i-Soler A, Fernandez-Ruanova B, Lopez-Heredia y Goya J, et al. A randomized comparison of surfactant dosing via a dual-lumen endotracheal tube in respiratory distress syndrome. The Spanish Surfactant Collaborative Group. Pediatrics. 1998 Apr;101(4):E4.
109. Van Meurs KP, Wright LL, Ehrenkranz RA, et al. Inhaled nitric oxide for premature infants with severe respiratory failure. N Engl J Med. 2005;353(1):13-22.
110. Vento M, Asensi M, Sastre J, Lloret A, Garcia-Sala F, Vina J. Oxidative stress in asphyxiated term infants resuscitated with 100% oxygen. J Pediatr. 2003;142(3):240-6.
111. Verder H, Albertsen P, Ebbesen F, et al. Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of <30 weeks' gestation. Pediatrics. 1999;103(2):e24.
112. Verlato G, Cogo PE, Benetti E, Gomirato S, Gucciardi A, Carnielli VP. Kinetics of surfactant in respiratory diseases of the newborn infant. J Matern Fetal Neonatal Med. 2004;16 Suppl 2:21-4.
113. Whitelaw A, Thoresen M. Antenatal steroids and the developing brain. Arch Dis Child Fetal Neonatal Ed. 2000;83(2):F154-7.
114. Woodgate PG, Davies MW: Permissive hypercapnia for the prevention of morbidity and mortality in mechanically ventilated newborn infants. Cochrane Database Syst Rev. 2001;(2):CD002061.